These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6977219)

  • 1. The role of IA in G-cell activation.
    Swain SL; Dutton RW
    Transplant Proc; 1981 Dec; 13(4):1843-5. PubMed ID: 6977219
    [No Abstract]   [Full Text] [Related]  

  • 2. Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens.
    Yu DT; McCune JM; Fu SM; Winchester RJ; Kunkel HG
    J Exp Med; 1980 Aug; 152(2 Pt 2):89s-98s. PubMed ID: 6967943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of autoantigen Ia recognition in T cell proliferative response].
    Ishii N; Nagai R; Okuda K
    Arerugi; 1983 Sep; 32(9):996-8. PubMed ID: 6607722
    [No Abstract]   [Full Text] [Related]  

  • 4. Level of Ia-like antigens on human B and T lymphocytes.
    Wilson BS; Indiveri F; Quaranta V; Pellegrino MA; Ferrone S
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1033-4. PubMed ID: 6973853
    [No Abstract]   [Full Text] [Related]  

  • 5. Ia antigen-stimulated proliferation and IL-2 production in the syngeneic mixed lymphocyte reaction.
    Lattime EC; Golub SH; Gillis S; Pecoraro GA; Stutman O
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1055-6. PubMed ID: 6455814
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of Ia-like antigens by a group A streptococcal product with mitogenic activity.
    Quagliata F; Beckerdite-Quagliata S; Russo C; Bisno A; Indiveri F; Pellegrino M; Ferrone S
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1049-50. PubMed ID: 7022915
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of T-cell activation by administration of MHC class II-binding peptides.
    Adorini L; Guéry JC
    Immunol Ser; 1993; 59():331-43. PubMed ID: 8461397
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmembrane signaling in T lymphocyte dependent B lymphocyte activation.
    Cambier JC
    Semin Immunol; 1989 Sep; 1(1):43-54. PubMed ID: 15630958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect recognition of pig class II antigens by human T cells.
    Yamada K; Sachs DH; DerSimonian H
    Transplant Proc; 1995 Feb; 27(1):258-9. PubMed ID: 7878993
    [No Abstract]   [Full Text] [Related]  

  • 10. Substitution of peptide bond 53-54 of HEL(52-61) with an ethylene bond rather than reduced peptide bond is tolerated by an MHC-II restricted T cell.
    Ettouati L; Salvi JP; Trescol-Biémont MC; Walchshofer N; Gerlier D; Rabourdin-Combe C; Paris J
    Pept Res; 1996; 9(5):248-53. PubMed ID: 9000251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
    Dennig D; O'Reilly RJ
    J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells.
    Vidal K; Samarut C; Magaud JP; Revillard JP; Kaiserlian D
    J Immunol; 1993 Nov; 151(9):4642-50. PubMed ID: 8409425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inside the professionals.
    Yewdell JW; Tscharke DC
    Nature; 2002 Aug; 418(6901):923-4. PubMed ID: 12198526
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
    Maeda H; Ogoshi S; Fujimoto S
    Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-V beta TcR monoclonal antibodies identify and can activate anergic T cells from mice rendered neonatally tolerant of class II alloantigens.
    Levy RB; Jones M; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):360-1. PubMed ID: 8438335
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunology. Chaperone puts the brakes on.
    Lukacs-Kornek V; Turley SJ
    Science; 2008 Dec; 322(5908):1640-1. PubMed ID: 19074333
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
    Setterblad N; Blancheteau V; Delaguillaumie A; Michel F; Bécart S; Lombardi G; Acuto O; Charron D; Mooney N
    J Leukoc Biol; 2004 Jun; 75(6):1036-44. PubMed ID: 14982950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression ability of Ia antigens on T cell subsets defined by monoclonal antibodies on pokeweed mitogen stimulation in early human life.
    Miyawaki T; Yachie A; Nagaoki T; Mukai M; Yokoi T; Uwadana N; Taniguchi N
    J Immunol; 1982 Jan; 128(1):11-5. PubMed ID: 7033371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.